Dialysis-associated hypertension treated with Telmisartan--DiaTel: a pilot, placebo-controlled, cross-over, randomized trial.

<h4>Unlabelled</h4>Treatment of hypertension in hemodialysis (HD) patients is characterised by lack of evidence for both the blood pressure (BP) target goal and the recommended drug class to use. Telmisartan, an Angiotensin receptor blocker (ARB) that is metabolised in the liver and not...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthias Huber, Till Treutler, Peter Martus, Antje Kurzidim, Reinhold Kreutz, Joachim Beige
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0263b6987ce24e419539ecf62afe9e46
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares